EFFECTIVENESS OF INFLIXIMAB IN PATIENTS WITH JUVENILE ANKYLOSING SPONDYLARTHRITIS
The objective of open-labeled study was estimation of effectiveness and safety of infliximab — monoclonal antibodies to tumor necrosis factor (TNF) - in treatment of 48 patients with juvenile ankylosing spondylarthritis. Duration of observation was 6 weeks — 1,5 years. Anticytokine treatment was adm...
Main Authors: | A.L. Kozlova, E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, A.M. Chomakhidze, K.B. Isaeva, R.V. Denisova, E.Yu. Gudkova, A.O. Lisitsin |
---|---|
Format: | Article |
Language: | English |
Published: |
"Paediatrician" Publishers LLC
2009-03-01
|
Series: | Вопросы современной педиатрии |
Online Access: | https://vsp.spr-journal.ru/jour/article/view/1085 |
Similar Items
-
EFFECTIVENESS OF INFLIXIMAB IN PATIENTS WITH JUVENILE ANKYLOSING SPONDYLARTHRITIS
by: A.L. Kozlova, et al.
Published: (2009-01-01) -
EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-01-01) -
EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS
by: E.I. Alexeeva, et al.
Published: (2009-07-01) -
TREATMENT WITH INFLIXIMAB IN PATIENT WITH EARLY POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS
by: T.V. Sleptsova, et al.
Published: (2010-09-01) -
TREATMENT WITH INFLIXIMAB IN PATIENT WITH EARLY POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS
by: T.V. Sleptsova, et al.
Published: (2010-01-01)